FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CNN3-ALG14

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CNN3-ALG14
FusionPDB ID: 17681
FusionGDB2.0 ID: 17681
HgeneTgene
Gene symbol

CNN3

ALG14

Gene ID

1266

199857

Gene namecalponin 3ALG14 UDP-N-acetylglucosaminyltransferase subunit
Synonyms-CMS15
Cytomap

1p21.3

1p21.3

Type of geneprotein-codingprotein-coding
Descriptioncalponin-3calponin 3, acidiccalponin, acidic isoformdJ639P13.2.2 (acidic calponin 3)UDP-N-acetylglucosamine transferase subunit ALG14 homolog
Modification date2020031320200313
UniProtAcc

Q15417

Main function of 5'-partner protein: FUNCTION: Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity.

Q96F25

Main function of 5'-partner protein: FUNCTION: May be involved in protein N-glycosylation. May play a role in the second step of the dolichol-linked oligosaccharide pathway. May anchor the catalytic subunit ALG13 to the ER. {ECO:0000269|PubMed:16100110}.
Ensembl transtripts involved in fusion geneENST idsENST00000370206, ENST00000394202, 
ENST00000538964, ENST00000487539, 
ENST00000545882, 
ENST00000495856, 
ENST00000370205, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 6 X 5=1507 X 7 X 5=245
# samples 910
** MAII scorelog2(9/150*10)=-0.736965594166206
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(10/245*10)=-1.29278174922785
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CNN3 [Title/Abstract] AND ALG14 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CNN3 [Title/Abstract] AND ALG14 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CNN3(95392394)-ALG14(95448862), # samples:6
ALG14(95492685)-CNN3(95369080), # samples:1
Anticipated loss of major functional domain due to fusion event.CNN3-ALG14 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CNN3-ALG14 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CNN3-ALG14 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
CNN3-ALG14 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:95392394/chr1:95448862)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CNN3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ALG14 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000370206CNN3chr195392394-ENST00000370205ALG14chr195492816-947344132583183
ENST00000538964CNN3chr195392394-ENST00000370205ALG14chr195492816-917214041824667161
ENST00000394202CNN3chr195392394-ENST00000370205ALG14chr195492816-933830643484833161

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000370206ENST00000370205CNN3chr195392394-ALG14chr195492816-0.085874280.9141257
ENST00000538964ENST00000370205CNN3chr195392394-ALG14chr195492816-0.082987560.91701245
ENST00000394202ENST00000370205CNN3chr195392394-ALG14chr195492816-0.0863523560.9136476

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CNN3-ALG14

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CNN3chr195392394ALG14chr195492816441136GPFLWALGRSQEQVYQILHSPNSKKP

Top

Potential FusionNeoAntigen Information of CNN3-ALG14 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CNN3-ALG14_95392394_95492816.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CNN3-ALG14chr195392394chr195492816441HLA-B13:02SQEQVYQI0.99380.7142917
CNN3-ALG14chr195392394chr195492816441HLA-B18:01QEQVYQIL0.98610.82511018
CNN3-ALG14chr195392394chr195492816441HLA-B13:01SQEQVYQI0.98140.9393917
CNN3-ALG14chr195392394chr195492816441HLA-B52:01SQEQVYQI0.970.9485917
CNN3-ALG14chr195392394chr195492816441HLA-B58:01RSQEQVYQI0.99460.9408817
CNN3-ALG14chr195392394chr195492816441HLA-B15:16RSQEQVYQI0.99260.81817
CNN3-ALG14chr195392394chr195492816441HLA-B58:02RSQEQVYQI0.98960.9509817
CNN3-ALG14chr195392394chr195492816441HLA-B15:17RSQEQVYQI0.9890.893817
CNN3-ALG14chr195392394chr195492816441HLA-A02:22ALGRSQEQV0.98160.694514
CNN3-ALG14chr195392394chr195492816441HLA-A02:13ALGRSQEQV0.97750.7672514
CNN3-ALG14chr195392394chr195492816441HLA-A02:27ALGRSQEQV0.97270.6987514
CNN3-ALG14chr195392394chr195492816441HLA-B57:03RSQEQVYQI0.97250.9842817
CNN3-ALG14chr195392394chr195492816441HLA-A02:38ALGRSQEQV0.96480.7478514
CNN3-ALG14chr195392394chr195492816441HLA-B39:01SQEQVYQIL0.94740.8863918
CNN3-ALG14chr195392394chr195492816441HLA-A32:13RSQEQVYQI0.93410.8949817
CNN3-ALG14chr195392394chr195492816441HLA-A02:19ALGRSQEQV0.92570.5701514
CNN3-ALG14chr195392394chr195492816441HLA-B18:01QEQVYQILH0.920.76011019
CNN3-ALG14chr195392394chr195492816441HLA-A30:08RSQEQVYQI0.90920.7264817
CNN3-ALG14chr195392394chr195492816441HLA-B39:13SQEQVYQIL0.88080.8818918
CNN3-ALG14chr195392394chr195492816441HLA-B38:02SQEQVYQIL0.83090.9576918
CNN3-ALG14chr195392394chr195492816441HLA-B13:01SQEQVYQIL0.81720.8504918
CNN3-ALG14chr195392394chr195492816441HLA-B38:01SQEQVYQIL0.80390.954918
CNN3-ALG14chr195392394chr195492816441HLA-B13:02RSQEQVYQI0.63880.8802817
CNN3-ALG14chr195392394chr195492816441HLA-B13:01RSQEQVYQI0.41240.9278817
CNN3-ALG14chr195392394chr195492816441HLA-B52:01RSQEQVYQI0.28060.9496817
CNN3-ALG14chr195392394chr195492816441HLA-B52:01SQEQVYQIL0.20070.7514918
CNN3-ALG14chr195392394chr195492816441HLA-B27:07GRSQEQVYQI0.99940.537717
CNN3-ALG14chr195392394chr195492816441HLA-B15:01ALGRSQEQVY0.99730.8602515
CNN3-ALG14chr195392394chr195492816441HLA-B15:25ALGRSQEQVY0.93660.9145515
CNN3-ALG14chr195392394chr195492816441HLA-B45:01QEQVYQILHSP0.99620.97941021
CNN3-ALG14chr195392394chr195492816441HLA-C15:04RSQEQVYQI0.99950.8492817
CNN3-ALG14chr195392394chr195492816441HLA-C15:06RSQEQVYQI0.99940.856817
CNN3-ALG14chr195392394chr195492816441HLA-C08:15SQEQVYQIL0.99620.9573918
CNN3-ALG14chr195392394chr195492816441HLA-C08:13SQEQVYQIL0.98510.9442918
CNN3-ALG14chr195392394chr195492816441HLA-C08:04SQEQVYQIL0.98510.9442918
CNN3-ALG14chr195392394chr195492816441HLA-A02:02ALGRSQEQV0.98110.5204514
CNN3-ALG14chr195392394chr195492816441HLA-C08:03SQEQVYQIL0.98090.9755918
CNN3-ALG14chr195392394chr195492816441HLA-B39:08SQEQVYQIL0.8580.7903918
CNN3-ALG14chr195392394chr195492816441HLA-B39:05SQEQVYQIL0.83060.8645918
CNN3-ALG14chr195392394chr195492816441HLA-C02:06RSQEQVYQI0.78310.9266817
CNN3-ALG14chr195392394chr195492816441HLA-C12:04RSQEQVYQI0.74870.9908817
CNN3-ALG14chr195392394chr195492816441HLA-C06:03RSQEQVYQI0.74030.9914817
CNN3-ALG14chr195392394chr195492816441HLA-B14:03SQEQVYQIL0.71490.6956918
CNN3-ALG14chr195392394chr195492816441HLA-B15:07ALGRSQEQVY0.9940.6332515
CNN3-ALG14chr195392394chr195492816441HLA-B15:04ALGRSQEQVY0.94950.8885515
CNN3-ALG14chr195392394chr195492816441HLA-B40:04QEQVYQIL0.99830.67931018
CNN3-ALG14chr195392394chr195492816441HLA-B18:05QEQVYQIL0.98610.82511018
CNN3-ALG14chr195392394chr195492816441HLA-B18:03QEQVYQIL0.97830.81181018
CNN3-ALG14chr195392394chr195492816441HLA-B41:03QEQVYQIL0.93620.65881018
CNN3-ALG14chr195392394chr195492816441HLA-C15:09RSQEQVYQI0.99950.8492817
CNN3-ALG14chr195392394chr195492816441HLA-C15:02RSQEQVYQI0.99950.7905817
CNN3-ALG14chr195392394chr195492816441HLA-C15:05RSQEQVYQI0.99950.9168817
CNN3-ALG14chr195392394chr195492816441HLA-C08:02SQEQVYQIL0.99620.9573918
CNN3-ALG14chr195392394chr195492816441HLA-C16:02RSQEQVYQI0.99090.9921817
CNN3-ALG14chr195392394chr195492816441HLA-A32:01RSQEQVYQI0.99080.92817
CNN3-ALG14chr195392394chr195492816441HLA-B57:04RSQEQVYQI0.98970.7444817
CNN3-ALG14chr195392394chr195492816441HLA-B58:06RSQEQVYQI0.98910.8859817
CNN3-ALG14chr195392394chr195492816441HLA-C08:01SQEQVYQIL0.98090.9755918
CNN3-ALG14chr195392394chr195492816441HLA-B39:02SQEQVYQIL0.96140.8873918
CNN3-ALG14chr195392394chr195492816441HLA-B39:31SQEQVYQIL0.96070.8882918
CNN3-ALG14chr195392394chr195492816441HLA-B57:02RSQEQVYQI0.9540.9397817
CNN3-ALG14chr195392394chr195492816441HLA-B18:05QEQVYQILH0.920.76011019
CNN3-ALG14chr195392394chr195492816441HLA-B18:06QEQVYQILH0.90030.7731019
CNN3-ALG14chr195392394chr195492816441HLA-B18:11QEQVYQILH0.87860.76811019
CNN3-ALG14chr195392394chr195492816441HLA-C17:01RSQEQVYQI0.86290.9713817
CNN3-ALG14chr195392394chr195492816441HLA-B39:11SQEQVYQIL0.85820.7597918
CNN3-ALG14chr195392394chr195492816441HLA-B38:05SQEQVYQIL0.80390.954918
CNN3-ALG14chr195392394chr195492816441HLA-B15:73SQEQVYQIL0.7540.654918
CNN3-ALG14chr195392394chr195492816441HLA-B15:30SQEQVYQIL0.68220.5893918
CNN3-ALG14chr195392394chr195492816441HLA-B27:06GRSQEQVYQI0.99930.6253717
CNN3-ALG14chr195392394chr195492816441HLA-B15:34ALGRSQEQVY0.99730.8602515
CNN3-ALG14chr195392394chr195492816441HLA-B15:33ALGRSQEQVY0.99730.8602515
CNN3-ALG14chr195392394chr195492816441HLA-B15:125ALGRSQEQVY0.99730.8602515
CNN3-ALG14chr195392394chr195492816441HLA-B15:27ALGRSQEQVY0.99710.8669515
CNN3-ALG14chr195392394chr195492816441HLA-B15:135ALGRSQEQVY0.9970.89515
CNN3-ALG14chr195392394chr195492816441HLA-B15:50ALGRSQEQVY0.99620.8918515
CNN3-ALG14chr195392394chr195492816441HLA-B15:35ALGRSQEQVY0.99350.8492515
CNN3-ALG14chr195392394chr195492816441HLA-B15:12ALGRSQEQVY0.98990.8972515
CNN3-ALG14chr195392394chr195492816441HLA-B15:39ALGRSQEQVY0.94160.8378515
CNN3-ALG14chr195392394chr195492816441HLA-B27:06GRSQEQVYQIL10.6613718
CNN3-ALG14chr195392394chr195492816441HLA-B27:09GRSQEQVYQIL0.99990.523718

Top

Potential FusionNeoAntigen Information of CNN3-ALG14 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CNN3-ALG14_95392394_95492816.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CNN3-ALG14chr195392394chr195492816441DRB1-0101EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0101QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0101SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0103EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0103QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0105EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0105QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0105SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0107EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0107QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0107SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0109EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0109QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0109SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0111EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0111QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0111SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0113EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0113QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0113SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0115EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0115QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0115SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0117EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0117QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0117SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0119EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0119QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0119SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0121EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0121QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0121SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0125EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0125QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0125SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0127EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0127QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0127SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0129EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0129QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0129SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0131EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0131QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0131SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0401EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0401QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0401SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0405EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0405QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0407EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0407QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0407SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0409EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0415EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0415QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0417EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0419EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0419QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0419SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0424EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0424QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0427EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0429EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0429QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0430EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0430QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0431EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0431QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0431SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0433EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0433QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0433SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0434EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0434QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0434SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0435EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0435QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0435SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0436EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0436QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0438EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0438QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0438SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0443EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0443QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0443SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0445EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0445QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0447EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0447QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0447SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0448EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0448QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0449EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0451EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0453EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0454EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0454QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0454SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0457EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0457QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0458EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0461EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0461QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0461SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0462EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0462QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0463EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0463QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0463SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0464EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0464QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0464SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0466EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0469EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0472EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0472QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0474EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0474QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0474SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0475EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0475QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0475SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0476EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0476QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0476SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0477EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0477QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0479EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0480EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0480QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0480SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0482EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0482QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0482SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-0483EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0483QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0484EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0484QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0486EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0486QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0487EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0487QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0489EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0489QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0802EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0802QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0803EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0807EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0807QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0808EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0809EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0809QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0811EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0813EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0813QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0814EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0815EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0815QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0819EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0821EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0821QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0823EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0824EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0824QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0825EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0827EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0830EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0830QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0832EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0832QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-0833EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0834EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0835EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0836EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0837EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-0838EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1001EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1001QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1001SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1003EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1003QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1003SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1105EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1105QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1108EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1119EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1127EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1130EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1130QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1130SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1131EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1137EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1145EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1164EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1169EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1172EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1172QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1180EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1187EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1216EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1216QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1216SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1307EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1326EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1326QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1347EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1356EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1358GPFLWALGRSQEQVY015
CNN3-ALG14chr195392394chr195492816441DRB1-1360EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1360QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1367EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1367QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1382EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1386EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1402EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1402QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1403EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1409EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1427EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1427QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1430EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1440EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1441EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1441QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1446EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1446QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1446SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1467EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1477EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1489EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1494EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1494QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1502EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1502QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1508EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1508QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1511EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1511QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1514EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1514QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1515EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1515QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1515SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1519EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1519QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1526EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1526QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1527EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1527QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1527SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1529EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1530EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1531EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1531QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1534EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1534QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1534SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1538EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1538QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1539EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1539QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1544EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1544QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1547EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1547QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1601EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1601QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1601SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1602EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1602QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1602SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1603EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1603QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1603SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1604EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1604QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1604SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1605EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1605QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1605SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1607EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1607QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1607SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1608EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1608QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1608SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1609EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1609QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1609SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1610EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1610QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1610SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1611EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1611QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1611SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1612EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1612QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1612SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1614EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1614QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1614SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB1-1615EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1616EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB1-1616QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB1-1616SQEQVYQILHSPNSK924
CNN3-ALG14chr195392394chr195492816441DRB3-0215EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB3-0217EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB3-0217QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB5-0102EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB5-0102QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB5-0103EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB5-0103QEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB5-0104EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB5-0108NEQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB5-0108NQEQVYQILHSPNSKK1025
CNN3-ALG14chr195392394chr195492816441DRB5-0111EQVYQILHSPNSKKP1126
CNN3-ALG14chr195392394chr195492816441DRB5-0203EQVYQILHSPNSKKP1126

Top

Fusion breakpoint peptide structures of CNN3-ALG14

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5028LGRSQEQVYQILHSCNN3ALG14chr195392394chr195492816441

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CNN3-ALG14

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5028LGRSQEQVYQILHS-7.9962-8.1096
HLA-B14:023BVN5028LGRSQEQVYQILHS-5.70842-6.74372
HLA-B52:013W395028LGRSQEQVYQILHS-6.83737-6.95077
HLA-B52:013W395028LGRSQEQVYQILHS-4.4836-5.5189
HLA-A11:014UQ25028LGRSQEQVYQILHS-10.0067-10.1201
HLA-A11:014UQ25028LGRSQEQVYQILHS-9.03915-10.0745
HLA-A24:025HGA5028LGRSQEQVYQILHS-6.56204-6.67544
HLA-A24:025HGA5028LGRSQEQVYQILHS-5.42271-6.45801
HLA-B44:053DX85028LGRSQEQVYQILHS-7.85648-8.89178
HLA-B44:053DX85028LGRSQEQVYQILHS-5.3978-5.5112
HLA-A02:016TDR5028LGRSQEQVYQILHS-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of CNN3-ALG14

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CNN3-ALG14chr195392394chr1954928161018QEQVYQILAAGAACAAGTATACCAAATACTAC
CNN3-ALG14chr195392394chr1954928161019QEQVYQILHAAGAACAAGTATACCAAATACTACATT
CNN3-ALG14chr195392394chr1954928161021QEQVYQILHSPAAGAACAAGTATACCAAATACTACATTCACCGA
CNN3-ALG14chr195392394chr195492816514ALGRSQEQVCTCTCGGCCGAAGTCAAGAACAAGTAT
CNN3-ALG14chr195392394chr195492816515ALGRSQEQVYCTCTCGGCCGAAGTCAAGAACAAGTATACC
CNN3-ALG14chr195392394chr195492816717GRSQEQVYQIGCCGAAGTCAAGAACAAGTATACCAAATAC
CNN3-ALG14chr195392394chr195492816718GRSQEQVYQILGCCGAAGTCAAGAACAAGTATACCAAATACTAC
CNN3-ALG14chr195392394chr195492816817RSQEQVYQIGAAGTCAAGAACAAGTATACCAAATAC
CNN3-ALG14chr195392394chr195492816917SQEQVYQIGTCAAGAACAAGTATACCAAATAC
CNN3-ALG14chr195392394chr195492816918SQEQVYQILGTCAAGAACAAGTATACCAAATACTAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CNN3-ALG14chr195392394chr195492816015GPFLWALGRSQEQVYGGCCCTTCCTATGGGCTCTCGGCCGAAGTCAAGAACAAGTATACC
CNN3-ALG14chr195392394chr1954928161025QEQVYQILHSPNSKKAAGAACAAGTATACCAAATACTACATTCACCGAATTCCAAGAAGC
CNN3-ALG14chr195392394chr1954928161126EQVYQILHSPNSKKPAACAAGTATACCAAATACTACATTCACCGAATTCCAAGAAGCCGG
CNN3-ALG14chr195392394chr195492816924SQEQVYQILHSPNSKGTCAAGAACAAGTATACCAAATACTACATTCACCGAATTCCAAGA

Top

Information of the samples that have these potential fusion neoantigens of CNN3-ALG14

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCACNN3-ALG14chr195392394ENST00000370206chr195492816ENST00000370205TCGA-A1-A0SH-01A

Top

Potential target of CAR-T therapy development for CNN3-ALG14

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CNN3-ALG14

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CNN3-ALG14

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource